{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:33:38Z","timestamp":1787315618150,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL096624"],"award-info":[{"award-number":["R01-HL096624"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL110837"],"award-info":[{"award-number":["HL110837"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ahj.2016.09.010","type":"journal-article","created":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T04:32:28Z","timestamp":1475814748000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy"],"prefix":"10.1016","volume":"182","author":[{"given":"Anna","family":"Grodzinsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne V.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Y.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praneet","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensey","family":"Gosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe Gabriel","family":"Steg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren K.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Spertus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan K.","family":"Chhatriwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2016.09.010_bb0005","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ahj.2007.11.017","article-title":"The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials","volume":"155","author":"Kumbhani","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.09.010_bb0010","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jacc.2004.10.075","article-title":"Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial","volume":"45","author":"Hermiller","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb0015","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2016.09.010_bb0020","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/01.CIR.0000116750.63158.94","article-title":"Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients","volume":"109","author":"West","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.010_bb0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.0000109693.64957.20","article-title":"Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"109","author":"Mathew","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.010_bb0030","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","article-title":"Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents","volume":"371","author":"Mauri","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2016.09.010_bb0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1479164111420890","article-title":"Variability of clopidogrel response in patients with type 2 diabetes mellitus","volume":"8","author":"Hall","year":"2011","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.ahj.2016.09.010_bb0040","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jacc.2008.07.068","article-title":"Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo","volume":"52","author":"Erlinge","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb0045","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2012.04869.x","article-title":"Safety and efficacy of protease-activated receptor-1 antagonists in patients with coronary artery disease: a meta-analysis of randomized clinical trials","volume":"10","author":"Capodanno","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2016.09.010_bb0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacc.2008.06.027","article-title":"What makes platelets angry: diabetes, fibrinogen, obesity, and impaired response to antiplatelet therapy?","volume":"52","author":"Bhatt","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb0055","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2337\/dc08-1865","article-title":"Factors contributing to increased platelet reactivity in people with diabetes","volume":"32","author":"Schneider","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2016.09.010_bb0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCOUTCOMES.108.791863","article-title":"Converting the informed consent from a perfunctory process to an evidence-based foundation for patient decision making","volume":"1","author":"Arnold","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2016.09.010_bb0065","series-title":"Computers in Cardiology, 2004","first-page":"193","article-title":"PRISM\u2122: a Web-based framework for deploying predictive clinical models","author":"Soto","year":"2004"},{"key":"10.1016\/j.ahj.2016.09.010_bb0070","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb0075","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.09.010_bb0080","series-title":"Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)","author":"Moscucci","year":"2003"},{"key":"10.1016\/j.ahj.2016.09.010_bb0085","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1016\/j.jacc.2005.09.080","article-title":"Correlates of bleeding events among moderate-to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT\u2013TIMI-30 trial","volume":"47","author":"Kirtane","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb0090","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/eurheartj\/ehm194","article-title":"Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach","volume":"28","author":"Nikolsky","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.09.010_bb0095","first-page":"222","article-title":"Bleeding in Patients Undergoing Percutaneous Coronary Intervention: The Development of a Clinical Risk Algorithm From the National Cardiovascular Data Registry. Circulation: Cardiovascular","volume":"2","author":"Mehta","year":"2009","journal-title":"Interventions"},{"key":"10.1016\/j.ahj.2016.09.010_bb0100","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/sim.1903","article-title":"Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study","volume":"23","author":"Lunceford","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2016.09.010_bb0105","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(09)60441-4","article-title":"Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial","volume":"373","author":"Montalescot","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2016.09.010_bb0110","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ahj.2016.09.010_bb0115","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.jacc.2013.02.044","article-title":"Nuisance bleeding with prolonged dual antiplatelet therapy after acute myocardial infarction and its impact on health status","volume":"61","author":"Amin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jacc.2015.10.034","article-title":"Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS","volume":"67","author":"Amin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.09.010_bb9000","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031630206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031630206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:35:29Z","timestamp":1778643329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031630206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":25,"alternative-id":["S000287031630206X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.09.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding risk following percutaneous coronary intervention in patients with diabetes prescribed dual anti-platelet therapy","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}